Cargando…
Who should be prioritised for COVID-19 vaccination?
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers i...
Autores principales: | Russell, Fiona M, Greenwood, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078651/ https://www.ncbi.nlm.nih.gov/pubmed/33141000 http://dx.doi.org/10.1080/21645515.2020.1827882 |
Ejemplares similares
-
Who should be prioritised for COVID-19 vaccines?
por: Hassan-Smith, Zaki, et al.
Publicado: (2020) -
Why we should not ‘just use age’ for COVID-19 vaccine prioritisation
por: Smith, Maxwell J
Publicado: (2022) -
A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy
por: Kristensen, Debra, et al.
Publicado: (2021) -
Should COVID-19 vaccination be made mandatory?
por: Iyengar, Karthikeyan P, et al.
Publicado: (2021) -
Prioritising the global response to curb the spread of COVID-19 in
the fragile settings of the Global South
por: Osama, Tasnime, et al.
Publicado: (2020)